Annual EBITDA
$123.69 M
+$11.61 M+10.36%
31 December 2023
Summary:
Astrana Health annual earnings before interest, taxes, depreciation & amortization is currently $123.69 million, with the most recent change of +$11.61 million (+10.36%) on 31 December 2023. During the last 3 years, it has risen by +$23.03 million (+22.88%). ASTH annual EBITDA is now at all-time high.ASTH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
$42.93 M
-$4.99 M-10.42%
30 September 2024
Summary:
Astrana Health quarterly earnings before interest, taxes, depreciation & amortization is currently $42.93 million, with the most recent change of -$4.99 million (-10.42%) on 30 September 2024. Over the past year, it has increased by +$31.68 million (+281.69%). ASTH quarterly EBITDA is now -64.27% below its all-time high of $120.16 million, reached on 01 June 2020.ASTH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
$138.79 M
-$3.17 M-2.23%
30 September 2024
Summary:
Astrana Health TTM earnings before interest, taxes, depreciation & amortization is currently $138.79 million, with the most recent change of -$3.17 million (-2.23%) on 30 September 2024. Over the past year, it has increased by +$15.10 million (+12.21%). ASTH TTM EBITDA is now -24.53% below its all-time high of $183.90 million, reached on 01 September 2020.ASTH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ASTH EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +281.7% | +12.2% |
| 3 y3 years | +22.9% | +353.0% | +37.9% |
| 5 y5 years | +153.2% | +418.9% | +184.1% |
ASTH EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +22.9% | -11.4% | +353.0% | -2.2% | +367.1% |
| 5 y | 5 years | at high | +315.8% | -64.3% | +129.4% | -24.5% | +591.2% |
| alltime | all time | at high | +1646.0% | -64.3% | +129.4% | -24.5% | +591.2% |
Astrana Health EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $42.93 M(-10.4%) | $138.79 M(-2.2%) |
| June 2024 | - | $47.92 M(+30.6%) | $141.96 M(+6.4%) |
| Mar 2024 | - | $36.69 M(+226.1%) | $133.40 M(+7.9%) |
| Dec 2023 | $123.69 M(+10.4%) | $11.25 M(-75.6%) | $123.69 M(-4.5%) |
| Sept 2023 | - | $46.10 M(+17.1%) | $129.53 M(-1.8%) |
| June 2023 | - | $39.37 M(+46.0%) | $131.87 M(+14.3%) |
| Mar 2023 | - | $26.97 M(+57.8%) | $115.33 M(+2.9%) |
| Dec 2022 | $112.08 M(+11.3%) | - | - |
| Dec 2022 | - | $17.09 M(-64.7%) | $112.08 M(+43.7%) |
| Sept 2022 | - | $48.44 M(+112.1%) | $78.02 M(+162.6%) |
| June 2022 | - | $22.83 M(-3.7%) | $29.71 M(-69.5%) |
| Mar 2022 | - | $23.71 M(-239.8%) | $97.42 M(-3.2%) |
| Dec 2021 | $100.66 M(+238.4%) | -$16.97 M(<-9900.0%) | $100.66 M(-456.2%) |
| Sept 2021 | - | $133.00 K(-99.9%) | -$28.26 M(-289.3%) |
| June 2021 | - | $90.54 M(+235.9%) | $14.93 M(-66.5%) |
| Mar 2021 | - | $26.95 M(-118.5%) | $44.55 M(+49.8%) |
| Dec 2020 | $29.74 M(-39.1%) | -$145.88 M(-436.8%) | $29.74 M(-83.8%) |
| Sept 2020 | - | $43.31 M(-64.0%) | $183.90 M(+14.4%) |
| June 2020 | - | $120.16 M(+888.8%) | $160.76 M(+166.9%) |
| Mar 2020 | - | $12.15 M(+46.9%) | $60.23 M(+23.3%) |
| Dec 2019 | $48.85 M(-52.3%) | $8.27 M(-59.0%) | $48.85 M(+15.4%) |
| Sept 2019 | - | $20.17 M(+2.7%) | $42.33 M(-47.3%) |
| June 2019 | - | $19.64 M(+2447.2%) | $80.39 M(+6.9%) |
| Mar 2019 | - | $771.00 K(-55.9%) | $75.17 M(-26.7%) |
| Dec 2018 | $102.49 M(+48.8%) | $1.75 M(-97.0%) | $102.49 M(+1.7%) |
| Sept 2018 | - | $58.23 M(+303.9%) | $100.74 M(+161.0%) |
| June 2018 | - | $14.42 M(-48.7%) | $38.60 M(+86.8%) |
| Mar 2018 | - | $28.09 M(-819.4%) | $20.67 M(-257.0%) |
| Dec 2017 | $68.87 M(-960.7%) | - | - |
| Sept 2017 | - | -$3.90 M(+11.1%) | -$13.16 M(+22.5%) |
| June 2017 | - | -$3.51 M(-22.2%) | -$10.74 M(+34.3%) |
| Mar 2017 | -$8.00 M(+8.8%) | -$4.52 M(+268.6%) | -$8.00 M(+6.2%) |
| Dec 2016 | - | -$1.23 M(-17.3%) | -$7.54 M(-0.3%) |
| Sept 2016 | - | -$1.48 M(+91.6%) | -$7.56 M(+17.9%) |
| June 2016 | - | -$773.60 K(-80.9%) | -$6.41 M(-14.5%) |
| Mar 2016 | -$7.35 M(-1642.0%) | -$4.05 M(+224.2%) | -$7.50 M(+146.8%) |
| Dec 2015 | - | -$1.25 M(+274.9%) | -$3.04 M(+14.5%) |
| Sept 2015 | - | -$333.50 K(-82.1%) | -$2.65 M(+1415.7%) |
| June 2015 | - | -$1.86 M(-559.2%) | -$175.10 K(-136.7%) |
| Mar 2015 | $476.70 K | $404.80 K(-146.7%) | $476.60 K(+563.8%) |
| Dec 2014 | - | -$866.40 K(-140.4%) | $71.80 K(-320.2%) |
| Sept 2014 | - | $2.15 M(-277.7%) | -$32.60 K(-98.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | -$1.21 M(+24.4%) | -$2.98 M(-22.3%) |
| Jan 2014 | -$3.83 M(-51.8%) | -$970.80 K(+21.7%) | -$3.83 M(+12.1%) |
| Oct 2013 | - | -$797.50 K(-41.1%) | -$3.41 M(-52.0%) |
| July 2013 | - | -$1.35 M(+92.0%) | -$7.11 M(-18.5%) |
| Apr 2013 | - | -$705.60 K(+26.7%) | -$8.73 M(+9.8%) |
| Jan 2013 | -$7.95 M(+1897.7%) | -$556.90 K(-87.6%) | -$7.95 M(+3.8%) |
| Oct 2012 | - | -$4.50 M(+51.2%) | -$7.66 M(+152.5%) |
| July 2012 | - | -$2.97 M(-4036.7%) | -$3.03 M(+2064.9%) |
| Apr 2012 | - | $75.50 K(-128.3%) | -$140.10 K(-64.9%) |
| Jan 2012 | -$397.90 K(+2226.9%) | -$266.50 K(-304.7%) | -$398.70 K(+162.3%) |
| Oct 2011 | - | $130.20 K(-264.2%) | -$152.00 K(-47.3%) |
| July 2011 | - | -$79.30 K(-56.7%) | -$288.30 K(+22.8%) |
| Apr 2011 | - | -$183.10 K(+824.7%) | -$234.70 K(+1272.5%) |
| Jan 2011 | -$17.10 K(-83.9%) | -$19.80 K(+224.6%) | -$17.10 K(-83.9%) |
| Oct 2010 | - | -$6100.00(-76.3%) | -$106.20 K(+36.3%) |
| July 2010 | - | -$25.70 K(-174.5%) | -$77.90 K(-512.2%) |
| Apr 2010 | - | $34.50 K(-131.7%) | $18.90 K(-117.7%) |
| Jan 2010 | -$106.40 K(-87.0%) | -$108.90 K(-590.5%) | -$106.50 K(+38.1%) |
| Oct 2009 | - | $22.20 K(-68.8%) | -$77.10 K(-81.2%) |
| July 2009 | - | $71.10 K(-178.2%) | -$410.50 K(-49.8%) |
| Apr 2009 | - | -$90.90 K(+14.3%) | -$818.40 K(+1.2%) |
| Jan 2009 | -$816.00 K(+2123.4%) | -$79.50 K(-74.5%) | -$808.50 K(+9.4%) |
| Oct 2008 | - | -$311.20 K(-7.6%) | -$738.90 K(+70.3%) |
| July 2008 | - | -$336.80 K(+360.7%) | -$433.80 K(+177.4%) |
| Apr 2008 | - | -$73.10 K(+825.3%) | -$156.40 K(+87.8%) |
| Mar 2008 | - | -$7900.00(-20.2%) | -$83.30 K(-4.4%) |
| Dec 2007 | -$36.70 K(+33.5%) | -$9900.00(+62.3%) | -$87.10 K(+2.2%) |
| Sept 2007 | - | -$6100.00(-89.7%) | -$85.20 K(-1.3%) |
| June 2007 | - | -$59.40 K(+407.7%) | -$86.30 K(+150.9%) |
| Mar 2007 | - | -$11.70 K(+46.3%) | -$34.40 K(+25.1%) |
| Dec 2006 | -$27.50 K(+106.8%) | -$8000.00(+11.1%) | -$27.50 K(+20.6%) |
| Sept 2006 | - | -$7200.00(-4.0%) | -$22.80 K(+14.6%) |
| June 2006 | - | -$7500.00(+56.3%) | -$19.90 K(+31.8%) |
| Mar 2006 | - | -$4800.00(+45.5%) | -$15.10 K(+12.7%) |
| Dec 2005 | -$13.30 K(+31.7%) | -$3300.00(-23.3%) | -$13.40 K(+20.7%) |
| Sept 2005 | - | -$4300.00(+59.3%) | -$11.10 K(+23.3%) |
| June 2005 | - | -$2700.00(-12.9%) | -$9000.00(-19.6%) |
| Mar 2005 | - | -$3100.00(+210.0%) | -$11.20 K(+9.8%) |
| Dec 2004 | -$10.10 K(+29.5%) | -$1000.00(-54.5%) | -$10.20 K(+10.9%) |
| Sept 2004 | - | -$2200.00(-55.1%) | -$9200.00(+31.4%) |
| June 2004 | - | -$4900.00(+133.3%) | -$7000.00(+233.3%) |
| Mar 2004 | - | -$2100.00 | -$2100.00 |
| Dec 2003 | -$7800.00 | - | - |
FAQ
- What is Astrana Health annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Astrana Health?
- What is Astrana Health quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Astrana Health?
- What is Astrana Health quarterly EBITDA year-on-year change?
- What is Astrana Health TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Astrana Health?
- What is Astrana Health TTM EBITDA year-on-year change?
What is Astrana Health annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of ASTH is $123.69 M
What is the all time high annual EBITDA for Astrana Health?
Astrana Health all-time high annual earnings before interest, taxes, depreciation & amortization is $123.69 M
What is Astrana Health quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of ASTH is $42.93 M
What is the all time high quarterly EBITDA for Astrana Health?
Astrana Health all-time high quarterly earnings before interest, taxes, depreciation & amortization is $120.16 M
What is Astrana Health quarterly EBITDA year-on-year change?
Over the past year, ASTH quarterly earnings before interest, taxes, depreciation & amortization has changed by +$31.68 M (+281.69%)
What is Astrana Health TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of ASTH is $138.79 M
What is the all time high TTM EBITDA for Astrana Health?
Astrana Health all-time high TTM earnings before interest, taxes, depreciation & amortization is $183.90 M
What is Astrana Health TTM EBITDA year-on-year change?
Over the past year, ASTH TTM earnings before interest, taxes, depreciation & amortization has changed by +$15.10 M (+12.21%)